4//SEC Filing
Broom Colin MD 4
Accession 0001104659-20-089136
CIK 0001641640other
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 4:53 PM ET
Size
7.2 KB
Accession
0001104659-20-089136
Insider Transaction Report
Form 4
Broom Colin MD
Chief Executive Officer
Transactions
- Award
Ordinary Shares
2020-07-29+17,500→ 226,250 total - Award
Stock Options
2020-07-29+35,000→ 35,000 totalExercise: $0.79Exp: 2030-07-28→ Ordinary Shares (35,000 underlying)
Footnotes (3)
- [F1]The reported transaction involved the reporting person's receipt of a grant of 17,500 restricted stock units. The total reported in Column 5 includes the 17,500 newly awarded restricted stock units.
- [F2]The option was granted on July 29, 2020.
- [F3]One hundred percent (100%) of the option will vest on July 31, 2021, subject to the reporting person's continued service on the board of directors of Nabriva Therapeutics plc.
Documents
Issuer
Nabriva Therapeutics plc
CIK 0001641640
Entity typeother
Related Parties
1- filerCIK 0001289946
Filing Metadata
- Form type
- 4
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 4:53 PM ET
- Size
- 7.2 KB